Intervention or expectant management for stage I twin-twin transfusion syndrome

Area of Science:

• Perinatology
• Maternal-Fetal Medicine
• Fetal Surgery

Background:

• Selective fetoscopic laser photocoagulation (SFLP) is standard for advanced twin-twin transfusion syndrome (TTTS).
• Optimal management for early-stage (stage I) TTTS remains unclear.
• Many stage I cases spontaneously resolve, but a significant portion progress to higher stages without identifiable risk factors.

Purpose of the Study:

• To review existing evidence comparing laser treatment and expectant management for stage I TTTS.
• To inform clinical decision-making for managing early-stage TTTS.

Main Methods:

• Literature review of PubMed and Google Scholar.
• Keywords used: "stage I," "twin transfusion," and "management."

Main Results:

• Expectant management is a reasonable first-line approach for stable, asymptomatic stage I TTTS.
• Selective fetoscopic laser photocoagulation (SFLP) is a viable option in specific stage I TTTS scenarios.
• Treatment for stage I TTTS should be individualized.

Conclusions:

• Stable, asymptomatic stage I TTTS can often be managed expectantly.
• Selective fetoscopic laser photocoagulation (SFLP) is indicated for select stage I TTTS cases.
• Individualized treatment decisions are crucial for stage I TTTS management.